Lars‐Olof Hattenbach

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

Ocular Disease, Ophthalmology, Age-related Diseases +4

PDE3A mutations cause autosomal dominant hypertension with brachydactyly

Philipp G. Maass, Friedrich C. Luft, Carolin Schächterle et al. · Nature Genetics · 2015 · 169 citations · Full text

Hypertension, Pde3a Mutations, Genetic Disorder +5

Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions

Lars‐Olof Hattenbach, Christina M. Klais, Frank Koch et al. · Ophthalmology · 2001 · 161 citations

Thrombosis, Intravitreous Injection, Vascular Surgery +9

Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

Yuichiro Ogura, Johann Roider, Jean‐François Korobelnik et al. · American Journal of Ophthalmology · 2014 · 158 citations

Ocular Disease, Vitreous Body, Ophthalmology +6

Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion

Lars‐Olof Hattenbach, I. Scharrer, H. Baatz · American Journal of Ophthalmology · 2008 · 120 citations

Thrombosis, Ocular Disease, Retina +10